Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
26 hedge funds and large institutions have $138M invested in Metacrine, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$31.4M |
| 2 |
VP
venBio Partners
San Francisco,
California
|
+$31.3M |
| 3 |
AG
Artal Group
Luxembourg
|
+$13.4M |
| 4 |
VA
VR Adviser
New York
|
+$11.7M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$10.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Millennium Management
New York
| $763 | +$769K | +75,163 | New |
|
MTCR Hedge Fund Activity: Q3 2020 in Review
26 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q3 2020, worth a combined $138M.
Buyers outnumbered sellers: 26 funds opened new MTCR positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $31.4M.
- 26 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $138M of Metacrine, Inc. Common Stock stock for Q3 2020.
- 26 funds opened new Metacrine, Inc. Common Stock positions in Q3 2020 and 0 closed out, a net change of +26 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q3 2020 was NEA Management Company, an estimated $31.4M added.
Based on aggregated 13F filings for Q3 2020.